BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 18727054)

  • 1. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
    Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
    J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B; Dong HP; Holth A; Berner A; Risberg B
    Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.
    Jacques N; Vimond N; Conforti R; Griscelli F; Lecluse Y; Laplanche A; Malka D; Vielh P; Farace F
    J Immunol Methods; 2008 Sep; 337(2):132-43. PubMed ID: 18662694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection.
    Belotti A; Elli E; Speranza T; Lanzi E; Pioltelli P; Pogliani E
    Am J Hematol; 2012 Mar; 87(3):319-20. PubMed ID: 22190201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer.
    Garcia JA; Rosenberg JE; Weinberg V; Scott J; Frohlich M; Park JW; Small EJ
    BJU Int; 2007 Mar; 99(3):519-24. PubMed ID: 17407512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.
    Simpson SJ; Vachula M; Kennedy MJ; Kaizer H; Coon JS; Ghalie R; Williams S; Van Epps D
    Exp Hematol; 1995 Sep; 23(10):1062-8. PubMed ID: 7544737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells in cancer patients do not express tissue factor.
    Beerepoot LV; Mehra N; Linschoten F; Jorna AS; Lisman T; Verheul HM; Voest EE
    Cancer Lett; 2004 Sep; 213(2):241-8. PubMed ID: 15327840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial cells: a novel marker of endothelial damage.
    Erdbruegger U; Haubitz M; Woywodt A
    Clin Chim Acta; 2006 Nov; 373(1-2):17-26. PubMed ID: 16836991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
    Goon PK; Boos CJ; Stonelake PS; Blann AD; Lip GY
    Thromb Haemost; 2006 Jul; 96(1):45-52. PubMed ID: 16807650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
    Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
    Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
    Rigolin GM; Maffei R; Rizzotto L; Ciccone M; Sofritti O; Daghia G; Cibien F; Cavazzini F; Marasca R; Cuneo A
    Cancer; 2010 Apr; 116(8):1926-37. PubMed ID: 20166207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.